Janet Rae

General Counsel at APPLIED GENETIC TECHNOLOGIES CORPORATION

Health Technology

Consumer Services

Profile

Janet C.
Rae is currently the Senior Vice President-Global Regulatory & Quality at Beacon Therapeutics (USA), Inc. Prior to this, she was the VP & Head-Gene Therapy Regulatory Affairs at Ultragenyx Pharmaceutical, Inc. from 2017 to 2021.
Before that, she was the Vice President & Head-Global Regulatory Affairs at Dimension Therapeutics, Inc. Ms. Rae completed her undergraduate degree at Gordon College (Georgia).

Janet Rae active positions

Companies	Position	Start
APPLIED GENETIC TECHNOLOGIES CORPORATION	General Counsel	2021-06-17

All active positions of Janet Rae

Former positions of Janet Rae

Companies	Position	End
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	2021-05-31
DIMENSION THERAPEUTICS INC	General Counsel	-

See the detail of Janet Rae's experience

Training of Janet Rae

Gordon College (Georgia)

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Janet Rae's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ULTRAGENYX PHARMACEUTICAL INC.	Health Technology

Private companies	2
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.	Health Technology
Dimension Therapeutics, Inc. Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA.	Health Technology